Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.46 |
| ▸ | ACE | P12821 | 12/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 5/20 | 0.45 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10071092 | 0.86 | ADORA3 (0.50) | F2ACENPSR1 | |
| SCHEMBL10071097 | 0.86 | F2 (0.60) | F2ACEACE2NPSR1 | |
| SCHEMBL10071095 | 0.82 | ACE (0.52) | ACE | |
| SCHEMBL10447086 | 0.75 | F2 (0.62) | F2ACE | |
| SCHEMBL10447085 | 0.75 | F2 (0.62) | F2ACE | |
| SCHEMBL4696097 | 0.75 | ACE (0.51) | F2ACE | |
| SCHEMBL15062947 | 0.75 | ACE (0.51) | F2ACE | |
| SCHEMBL10082599 | 0.75 | F2 (0.53) | F2ACENPSR1 | |
| SCHEMBL10071088 | 0.73 | ADORA3 (0.51) | F2ACEMMEL1 | |
| SCHEMBL10752888 | 0.73 | ACE (0.52) | ACEACE2MMEMMEL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | BRACCO IMAGING SPA (IT) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | LHCGR, GNRHR, FSHR | F2 4130/4885ACE 2838/4885ACE2 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.